Global Cannabidiol (CBD) Market 2023-2029

Global Cannabidiol (CBD) Market 2023-2029

The global cannabidiol market is projected to rise by USD 14.0 billion by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of 13.5 percent during the forecast period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global cannabidiol market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for cannabidiol can be segmented by product: edibles, flower, oil & tinctures, pills & capsules, topicals, others. The oil & tinctures segment was the largest contributor to the global cannabidiol market in 2022. Cannabidiol market is further segmented by application: beauty and personal care, medicinal , pet foods, recreational. According to the research, the medicinal segment had the largest share in the global cannabidiol market. Based on region, the cannabidiol market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest revenue share in 2022.

Market Segmentation

By product: edibles, flower, oil & tinctures, pills & capsules, topicals, others

By application: beauty and personal care, medicinal , pet foods, recreational

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report explores the recent developments and profiles of key vendors in the Global Cannabidiol Market, including Aphria Inc., Aurora Cannabis Inc., Canopy Growth Corporation, Cronos Group Inc., CV Sciences Inc., Elixinol Wellness Limited, Endoca BV, Gaia Botanicals LLC D/B/A Bluebird Botanicals, GW Pharmaceuticals plc, Hemp Inc., Isodiol International Inc., Medical Marijuana Inc, Organigram Holdings Inc., Shaman Botanicals LLC dba CBD American Shaman, Tikun Olam LLC, Tilray Brands, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report

• To analyze and forecast the market size of the global cannabidiol market.
• To classify and forecast the global cannabidiol market based on product, application, region.
• To identify drivers and challenges for the global cannabidiol market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cannabidiol market.
• To identify and analyze the profile of leading players operating in the global cannabidiol market.

• Gain a reliable outlook of the global cannabidiol market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.